491 related articles for article (PubMed ID: 31801262)
21. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic Understanding of Curcumin's Therapeutic Effects in Lung Cancer.
Wan Mohd Tajuddin WNB; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817718
[TBL] [Abstract][Full Text] [Related]
23. Recent advances of analogues of curcumin for treatment of cancer.
Zhao S; Pi C; Ye Y; Zhao L; Wei Y
Eur J Med Chem; 2019 Oct; 180():524-535. PubMed ID: 31336310
[TBL] [Abstract][Full Text] [Related]
24. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
25. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
26. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
27. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
28. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma.
Luthra PM; Lal N
Eur J Med Chem; 2016 Feb; 109():23-35. PubMed ID: 26748069
[TBL] [Abstract][Full Text] [Related]
29. Highly active anticancer curcumin analogues.
Mosley CA; Liotta DC; Snyder JP
Adv Exp Med Biol; 2007; 595():77-103. PubMed ID: 17569206
[TBL] [Abstract][Full Text] [Related]
30. Curcumin effect on cancer cells' multidrug resistance: An update.
Keyvani-Ghamsari S; Khorsandi K; Gul A
Phytother Res; 2020 Oct; 34(10):2534-2556. PubMed ID: 32307747
[TBL] [Abstract][Full Text] [Related]
31. Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal BB; Kumar A; Bharti AC
Anticancer Res; 2003; 23(1A):363-98. PubMed ID: 12680238
[TBL] [Abstract][Full Text] [Related]
32. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
33. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma.
Salehi M; Movahedpour A; Tayarani A; Shabaninejad Z; Pourhanifeh MH; Mortezapour E; Nickdasti A; Mottaghi R; Davoodabadi A; Khan H; Savardashtaki A; Mirzaei H
Phytother Res; 2020 Oct; 34(10):2557-2576. PubMed ID: 32307773
[TBL] [Abstract][Full Text] [Related]
35. Curcumin: a promising agent targeting cancer stem cells.
Zang S; Liu T; Shi J; Qiao L
Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
[TBL] [Abstract][Full Text] [Related]
36. Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers.
Ashrafizadeh M; Zarrabi A; Hashemipour M; Vosough M; Najafi M; Shahinozzaman M; Hushmandi K; Khan H; Mirzaei H
Pharmacol Res; 2020 Oct; 160():105199. PubMed ID: 32942019
[TBL] [Abstract][Full Text] [Related]
37. The clinical applications of curcumin: current state and the future.
Fan X; Zhang C; Liu DB; Yan J; Liang HP
Curr Pharm Des; 2013; 19(11):2011-31. PubMed ID: 23116310
[TBL] [Abstract][Full Text] [Related]
38. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
39. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
[TBL] [Abstract][Full Text] [Related]
40. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway.
Choi BH; Kim CG; Lim Y; Shin SY; Lee YH
Cancer Lett; 2008 Jan; 259(1):111-8. PubMed ID: 18006147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
